Events with Recording

  • Read more: Climate Change and Health: A Health Policy and Bioethics Consortium
    Feb 10

    Climate Change and Health: A Health Policy and Bioethics Consortium

    Event Description As one of the largest economic sectors globally, health care represents nearly 10% of GDP spending across O.E.C.D. countries. This significant activity produces an estimated 5-10% of global greenhouse gases, presenting opportunities to directly reduce this impact through changes to energy supply, waste, purchasing, and care models. Equally important, health care has a…

  • Read more: What Magic Can Teach Us About Misinformation
    Jan 13

    What Magic Can Teach Us About Misinformation

    Event Description This panel joined together the fields of medicine, magic, and ethics. We explored how misinformation and disinformation about health is created and spread, and how expectation violation theory, a theory of communication that analyzes how individuals respond to unanticipated violations of social norms and expectations, can help to counteract these narratives. The panel also discussed…

  • Read more: Comparing Legal Approaches to Accessing Psychedelics
    Dec 7

    Comparing Legal Approaches to Accessing Psychedelics

    Event Description Voters, lawmakers, and healthcare providers are experimenting with legal approaches to accessing psychedelics. Some take medical approaches by allocating funds for research or leveraging controversial federal policies like right-to-try or expanded access. Others reduce criminal penalties or create regulatory systems outside the federal framework, allowing access to psychedelics for promoting mental and physical…

  • Read more: What Can the Psychedelics Industry Learn from Cannabis Regulation?
    Nov 10

    What Can the Psychedelics Industry Learn from Cannabis Regulation?

    Event Description Psychedelics have recently become a serious topic of legal reform and intense commercial investment. In the past few years, dozens of cities and states have enacted or proposed legislation to decriminalize or regulate psychedelics like psilocybin, dimethyltryptamine, mescaline, and ibogaine. Meanwhile, billions of dollars are flowing into psychedelic companies that are researching, patenting,…

  • Read more: Book Talk: Choose Your Medicine: Freedom of Therapeutic Choice in America
    Nov 3

    Book Talk: Choose Your Medicine: Freedom of Therapeutic Choice in America

    Event Description On November 3rd, we hosted a book talk and moderated discussion with author Lewis A. Grossman on his new book, Choose Your Medicine: Freedom of Therapeutic Choice in America, and respondent William M. Sage, Professor of Law and Medicine at Texas A&M University. In Choose Your Medicine, Grossman explores the history and impacts…

  • Read more: Life Sentences for Children?: The Neuroscientific Basis for Limitations on Harsh Sentencing
    Oct 27

    Life Sentences for Children?: The Neuroscientific Basis for Limitations on Harsh Sentencing

    Event Description Neuroscience is playing a key role in legal decisions about children and young adults serving life sentences. The US Supreme Court relied upon research on adolescent brain development to bar execution and limit sentences of Life Without Possibility of Parole for crimes committed under age 18. However, the U.S. Supreme Court case Jones v….

  • Read more: Abortion Rights and Reproductive Justice in Latin America: Recent Landmark Decisions from Mexico and Colombia
    Oct 21

    Abortion Rights and Reproductive Justice in Latin America: Recent Landmark Decisions from Mexico and Colombia

    Event Description As the U.S. Supreme Court reversed half a century of jurisprudence in Dobbs, rejecting a fundamental right to abortion, courts across Latin America have made progress in the opposite direction. A so-called “Green Wave” has swept across some of the most populous countries in a region that was formerly known for having the…

  • Read more: FDA and Emergency Response
    Sep 20

    FDA and Emergency Response

    Learn more about the FDA’s emergency response to issues such as COVID-19, monkeypox, and infant formula. On September 20th, we hosted a discussion of these topics and more with FDA Principal Deputy Chief Counsel Mark Raza in conversation with PFC Faculty Director, I. Glenn Cohen. Panelists This event was sponsored by the Petrie-Flom Center for Health Law…

  • Read more: Creating Sustainable Infrastructure for Pandemic Preparedness and Response
    Sep 14

    Creating Sustainable Infrastructure for Pandemic Preparedness and Response

    Event Description The COVID-19 pandemic has reinvigorated the national and global conversation about disrupting the panic-neglect cycle in public health. It has also shown us that no single sector can do this alone—for instance, the rapid delivery of mRNA vaccines and the establishment of large-scale, end-to-end testing infrastructure for COVID-19 were products of private-sector innovation…

  • Read more: Dobbs v. Jackson: Understanding the Post-Roe Landscape
    Jun 29

    Dobbs v. Jackson: Understanding the Post-Roe Landscape

    Event Description The Supreme Court decision for Dobbs v. Jackson Women’s Health Organization has shocked the country. The United States is now living in a post-Roe world, and the right to abortion has lost its constitutional protection. In this discussion, we analyzed this landmark decision, its underpinnings, and its impacts for abortion and other areas of law. Audience…